Drug induced myopathy Edition

Slides:



Advertisements
Similar presentations
Statins in Renal Failure Andrea Fox Sunnybrook Health Science Center May 2010.
Advertisements

© 2006 National Lipid Association Statin Safety: Key Conclusions and Recommendations of the NLA.
Clinical question: When do you get statin induced myopathy?
Anti-Hypercholesterolemic Agents  Biosynthesis and Metabolism of Cholesterol  What is arteriosclerosis? - Link between arteriosclerosis and cholesterol.
Livalo (Pitavastatin)
Kirk Mykytyn, Ph.D. Department of Pharmacology
New Agents Heather Kertland, PharmD.
Antihyperlipidemia.
STATINS AGAIN. Atorvastatin Off patent Atorvastatin 40 = £36 PA Simvastatin 40 = £14 PA Atorvastatin 80 = £72 PA Simvastatin 80 = £24 PA.
Praluent® - alirocumab
Slide Source: Lipids Online Slide Library Initiating and Monitoring Statin Therapy Kimberly K. Birtcher, MS, PharmD, BCPS (AQ Cardiology),
Team Based Care Combining Team Based Care and Technology to Improve Quality and Transform Healthcare to Improve Blood Pressure Control Wednesday February.
Statin Induce Myotoxicity
Endocrinologic & Metabolic Drugs Advisory Committee Meeting
Manufacturer: Amgen Inc FDA Approval Date: August 27, 2015
ACC/AHA Guidelines Not the Final or Only Word. Contemporary Guidelines
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Scott W. Rypkema, M.D.
Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.
Efficiently dealing with new FDA information on drug safety Warnings, Shortages, Withdrawals – Oh My! Efficiently dealing with new FDA information on drug.
R1. 이정미 / prof. 김우식. INTRODUCTION Reduction in low-density lipoprotein (LDL) cholesterol levels has proved to be highly effective in reducing rates of.
Therapeutics 1 Tutoring
North Bay Educational Symposium CANP North Bay Chapter January 30, 2016 Gregg Hopkins, MD, FACC Sutter Medical Group of the Redwoods.
Hyperlipidemia: Management of Patients in the Primary Care Setting
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated.
18th Annual Primary Care & Cardiovascular Symposium
Repatha ( Evolocumab) Praluent (Arilocumab)
Journal of the American College of Cardiology
PGx Logical Overview.
Statins induced myopathy
Evolocumab Drugbank ID : DB09303.
Managing Lipid Disorders
Anti-Hypercholesterolemic Agents
Familial Hypercholesterolaemia
Intensive Statin Recommendations
Statin Myopathy: Massive Rhabdomyolysis from Inadvertent Use of Two Statins Dinesh Kadariya MD, Kamran Zahid MD, TS Dharmarajan MD, FACP, AGSF Dept.
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Drugs for Hyperlipidemias
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
Non-cardiovascular effects associated with statins Chintan S Desai, Seth S Martin, Roger S Blumenthal STATE OF THE ART REVIEW BMJ 2014;349:g3743.
Antilipidaemic agents
Comprehensive Diabetes Care
A multicenter, double-blind, randomized study to establish the clinical benefit and safety of ezetimibe/simvastatin tablet (vytorin) vs simvastatin.
Patients aged 85yrs and over
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial.
Understanding Statin Metabolism
Lipid Treatment Updates in Management
Statin Class in Session
An Update on PCSK9 Inhibitors
Evaluating LDL-C Recommendations
Statin Class in Session
My Approach to the Patient With Familial Hypercholesterolemia
% decrease in LDL-C at 24 weeks from baseline
A Patient Journey Through Statin Intolerance
Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia  Joep C. Defesche, PhD,
Clinicians' Corner in Dyslipidemia
TREATMENT OF THE ACUTE GOUT ATTACK:
LRC-CPPT and MRFIT Content Points:
An Update on PCSK9 Inhibitors
Major classes of drugs to reduce lipids
Train-the-Trainer Cases
Pandemic Lipid Edition
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Train-the-Trainer Cases
Train-the-Trainer Cases
Lipids, the Heart, and the Kidney
Putting Your Skills to the Test
Pharmacological approaches to improve cardiovascular health
PCSK9 Inhibitors and Real-World Evidence
Follow-up: considerations
Section 6: Update on lipid treatment guidelines
Presentation transcript:

Drug induced myopathy Edition A team-based mission to combat myopathy

Meijer Pharmacy offers what statin for free? Atorvastatin 10-80 mg

What is the specific statin agent and dose that is still on the market, but not recommended for initiation? X Simvastatin 80 mg Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80-mg dose of ZOCOR should be restricted to patients who have been taking simvastatin 80 mg chronically (e.g., for 12 months or more) without evidence of muscle toxicity. (2.2)

List at least two simvastatin drug-drug interactions - including max dose limitations Interacting Agents Simvastatin Recommendations Strong CYP3A4 inhibitors Contraindicated Verapamil, diltiazem, dronedarone 10 mg/day max Amlodipine, amiodarone, ranolazine 20 mg/day max Strong CYP3A4 inhibitors (e.g., itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, cobicistat- containing products), gemfibrozil, cyclosporine, danazol

Which statins include grapefruit juice precaution? L A S: Lovastatin, atorvastatin, simvastatin 8 oz of juice or 1 half a grapefruit unlikely to cause an issue – 3A4

Which statin does not require dose adjustment in renal impairment? Atorvastatin At what age is moderate considered adequate for high risk patients? (age 75)

Mary is starting a 10 day course of clarithromycin Mary is starting a 10 day course of clarithromycin. She also takes atorvastatin 40 mg. What should you do? Nothing – there is no drug interaction Counsel her to stop statin while on the antibiotic Call the physician to have her statin switched to Pravastatin At what age is moderate considered adequate for high risk patients? (age 75)

Which two statins are considered “sensitive substrates” because their concentrations can be increased 5x by CYP3A4 inhibitors Simvastatin and lovastatin Strong CYP3A4 inhibitors: Clarithromycin, intraconazole

Which statin has a max dose of 10 mg with select protease inhibitors? Rosuvastatin Limit to 10 mg with lopinavir/ritonavir or atazanavir/ritonavir

Which statin is specifically market as being less likely to cause DDI? Pitavastatin (livalo) https://www.livalorx.com

What OTC product is commonly used to prevent statin induced myopathy? Coenzyme Q10 (ubiquinol) 100-200 mg daily

Which medication used for TG lowering should be avoid with statins? Gemfibrozil

What are two lab levels that may be helpful to rule out other causes of myalgia? TSH Vitamin D

Heart Center of Excellence (bonus points)

The Improve-it provided outcomes data with what medication? Vytorin (ezetimibe and simvastatin)

What new class of lipid-lowering medications was recently FDA approved? PCSK9 Inhibitors Praluent (alirocumab) Repatha (evolocumab) PRALUENT (alirocumab) is a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) inhibitor antibody indicated as adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease, who require additional lowering of LDL-C. The effect of PRALUENT on cardiovascular morbidity and mortality has not been determined.

The race to prevent myopathy  Decreased ETOH Renally adjust Address drug interactions Evaluate other causes Lower dose Switch statin Use extended regimen Patient education

Rhabdomyolysis risks Myalgia, weakness, dark urine Acute kidney injury Bing drinking trauma elderly Drug interactions Illicit drugs statin fasciotomy